WallStreetZen

NASDAQ: LMAT
Lemaitre Vascular Inc Stock Forecast, Predictions & Price Target

Analyst price target for LMAT

Based on 3 analysts offering 12 month price targets for Lemaitre Vascular Inc.
Min Forecast
$55.00-1.29%
Avg Forecast
$61.00+9.48%
Max Forecast
$70.00+25.63%

Should I buy or sell LMAT stock?

Based on 4 analysts offering ratings for Lemaitre Vascular Inc.
Buy
Strong Buy
1 analysts 25%
Buy
0 analysts 0%
Hold
3 analysts 75%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

LMAT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDate
Jefferies
Top 21%
80
Strong BuyInitiates Coverage On$70.00+25.63%2021-09-16
Roth Capital
Top 24%
77
HoldMaintains$58.00+4.09%2021-08-03
Anonymous
Roth Capital
HoldMaintains$55.00-1.29%2021-05-04
KeyBanc
Top 15%
86
HoldInitiates Coverage OnN/AN/A2021-02-12

1 of 1

Forecast return on equity

Is LMAT forecast to generate an efficient return?
Company
20.75%
Industry
17.09%
Market
2,530.69%
LMAT's Return on Equity is forecast to be high in 3 years (20.75%); analysts are confident in the firm's ability to efficiently generate return on equity
Forecast

Forecast return on assets

Is LMAT forecast to generate an efficient return on assets?
Company
15.64%
Industry
9.44%
Market
1,237.47%
LMAT is forecast to generate higher Return on Assets (15.64%) than the US Medical Instruments & Supplies industry average (9.44%)
Forecast

LMAT earnings per share forecast

What is LMAT's earnings per share in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
$1.36-3.55%
Avg 2 year Forecast
$1.51+7.09%
Avg 3 year Forecast
$1.64+16.31%
LMAT's earnings are forecast to grow at a rate of 5.25% per year, which is not exceptional
Forecast

LMAT revenue forecast

What is LMAT's revenue in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
$156.5M+3.96%
Avg 2 year Forecast
$167.4M+11.21%
Avg 3 year Forecast
$177.6M+17.99%
LMAT's revenue is forecast to grow at a rate of 5.7% per year, which is not exceptional
Forecast

LMAT earnings growth forecast

How is LMAT forecast to perform vs Medical Instruments & Supplies companies and vs the US market?
Company
5.25%
Industry
20.64%
Market
18.62%
LMAT's earnings are forecast to grow slower (5.25% per year) than the US Medical Instruments & Supplies industry average (20.64%)
Forecast
LMAT's earnings are forecast to grow slower (5.25% per year) than the US market average (18.62%)
Forecast
LMAT's earnings are forecast to grow faster (5.25% per year) than the risk-free savings rate (1.5%)
Forecast

LMAT revenue growth forecast

How is LMAT forecast to perform vs Medical Instruments & Supplies companies and vs the US market?
Company
5.7%
Industry
8.08%
Market
12.38%
LMAT's revenues are forecast to grow slower (5.7% per year) than the US Medical Instruments & Supplies industry average (8.08%)
Forecast
LMAT's revenues are forecast to grow slower (5.7% per year) than the US market average (12.38%)
Forecast

Lemaitre Vascular Stock Forecast FAQ

Is Lemaitre Vascular Stock a good buy in 2021, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: LMAT) stock is to Buy LMAT stock.

Out of 4 analysts, 1 (25%) are recommending LMAT as a Strong Buy, 0 (0%) are recommending LMAT as a Buy, 3 (75%) are recommending LMAT as a Hold, 0 (0%) are recommending LMAT as a Sell, and 0 (0%) are recommending LMAT as a Strong Sell.

What is LMAT's earnings growth forecast for 2021-2023?

(NASDAQ: LMAT) Lemaitre Vascular's forecast annual earnings growth rate of 5.25% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast earnings growth rate of 20.64%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.62%.

Lemaitre Vascular's earnings in 2021 is $28,774,000.On average, 5 Wall Street analysts forecast LMAT's earnings for 2021 to be $29,458,912, with the lowest LMAT earnings forecast at $29,025,693, and the highest LMAT earnings forecast at $30,325,351. On average, 5 Wall Street analysts forecast LMAT's earnings for 2022 to be $32,708,057, with the lowest LMAT earnings forecast at $32,058,228, and the highest LMAT earnings forecast at $33,574,496.

In 2023, LMAT is forecast to generate $35,523,983 in earnings, with the lowest earnings forecast at $35,090,763 and the highest earnings forecast at $36,390,421.

What is LMAT's revenue growth forecast for 2021-2023?

(NASDAQ: LMAT) Lemaitre Vascular's forecast annual revenue growth rate of 5.7% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.08%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12.38%.

Lemaitre Vascular's revenue in 2021 is $150,517,000.On average, 5 Wall Street analysts forecast LMAT's revenue for 2021 to be $3,389,507,803, with the lowest LMAT revenue forecast at $3,368,280,058, and the highest LMAT revenue forecast at $3,412,251,816. On average, 5 Wall Street analysts forecast LMAT's revenue for 2022 to be $3,625,720,627, with the lowest LMAT revenue forecast at $3,554,564,357, and the highest LMAT revenue forecast at $3,684,291,876.

In 2023, LMAT is forecast to generate $3,847,030,706 in revenue, with the lowest revenue forecast at $3,732,184,270 and the highest revenue forecast at $3,923,017,371.

What is LMAT's forecast return on assets (ROA) for 2021-2024?

(NASDAQ: LMAT) forecast ROA is 15.64%, which is higher than the forecast US Medical Instruments & Supplies industry average of 9.44%.

What is LMAT's Price Target?

According to 3 Wall Street analysts that have issued a 1 year LMAT price target, the average LMAT price target is $61.00, with the highest LMAT stock price forecast at $70.00 and the lowest LMAT stock price forecast at $55.00.

On average, Wall Street analysts predict that Lemaitre Vascular's share price could stay at $61.00 by Sep 16, 2022. The average Lemaitre Vascular stock price prediction forecasts a potential downside of N/A from the current LMAT share price of $55.72.

What is LMAT's Earnings Per Share (EPS) forecast for 2021-2023?

(NASDAQ: LMAT) Lemaitre Vascular's current Earnings Per Share (EPS) is $1.41. On average, analysts forecast that LMAT's EPS will be $1.36 for 2021, with the lowest EPS forecast at $1.34, and the highest EPS forecast at $1.40. On average, analysts forecast that LMAT's EPS will be $1.51 for 2022, with the lowest EPS forecast at $1.48, and the highest EPS forecast at $1.55. In 2023, LMAT's EPS is forecast to hit $1.64 (min: $1.62, max: $1.68).

What is LMAT's forecast return on equity (ROE) for 2021-2024?

(NASDAQ: LMAT) forecast ROE is 20.75%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.